Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities

Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related deaths, following pancreatic cancer. The 5-year overall survival rate for HCC remains relatively low. Currently, there are multiple treatment options available for HCC, including systemic drugs,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Advanced pharmaceutical bulletin 2024-10, Vol.14 (3), p.513-523
Hauptverfasser:	Asgharzadeh, Fereshteh, Moradi Binabaj, Maryam, Fanoudi, Sahar, C Cho, William, Yang, Yu-Jeong, Azarian, Maryam, Shafiee Ardestani, Mehdi, Nasiri, Nasim, Ramezani Farani, Marzieh, Huh, Yun Suk
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Cancer therapies Cell growth Cholangiocarcinoma Drug resistance FDA approval Hepatitis Immunotherapy Kinases Lipids Liver cancer Liver diseases Mechanical properties Mortality Mutation Nanoparticles Pancreatic cancer Permeability Review Stem cells Transcription factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!